Finance

Beta
Lists
ALTHE:EPA
Theraclion SA
€0.73
+2.82%
(+0.020) 1D
Jun 3, 5:35:25 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for ALTHE...
Open
€0.71
High
€0.75
Low
€0.69
Mkt. cap
51.92M
Avg. vol.
209.80K
Volume
147.10K
52-wk high
€1.25
52-wk low
€0.28
EPS
-€0.10
Shares outstanding
73.12M
No. of employees
36
Open
€0.71
High
€0.75
Low
€0.69
Mkt. cap
51.92M
Avg. vol.
209.80K
Volume
147.10K
52-wk high
€1.25
52-wk low
€0.28
EPS
-€0.10
Shares outstanding
73.12M
No. of employees
36
News stories
From sources across the web
About Theraclion SA
CEODavid Auregan
Employees36
Founded2004
Headquarters-
SectorMedical device
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in EUR
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
472.00K
472.00K
-146.00K
-146.00K
Cost of goods sold
964.50K
964.50K
897.00K
897.00K
Cost of revenue
964.50K
964.50K
897.00K
897.00K
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
893.00K
893.00K
942.50K
942.50K
Operating expense
915.50K
915.50K
1.42M
1.42M
Total operating expenses
1.88M
1.88M
2.32M
2.32M
Operating income
-1.41M
-1.41M
-2.46M
-2.46M
Other non operating income
-
-
500.00
500.00
EBT including unusual items
-1.51M
-1.51M
-1.76M
-1.76M
EBT excluding unusual items
-1.48M
-1.48M
-2.46M
-2.46M
Income tax expense
-237.50K
-237.50K
-181.00K
-181.00K
Effective tax rate
15.77%
15.77%
10.30%
10.30%
Other operating expenses
-64.50K
-64.50K
367.00K
367.00K
Net income
-1.27M
-1.27M
-1.58M
-1.58M
Net profit margin
-268.86%
-268.86%
1,079.45%
1,079.45%
Earnings per share
-
-
-
-
Interest and investment income
-
-
9.50K
9.50K
Interest expense
-71.50K
-71.50K
-9.50K
-9.50K
Net interest expenses
-71.50K
-71.50K
-
-
Depreciation and amortization charges
87.00K
87.00K
112.50K
112.50K
EBITDA
-1.33M
-1.33M
-2.34M
-2.37M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more